Cargando…
Oncogenic microRNA-181d binding to OGT contributes to resistance of ovarian cancer cells to cisplatin
Ovarian cancer (OC), a common gynecological cancer, is characterized by a high malignant potential. MicroRNAs (miRNAs or miRs) have been associated with the chemo- or radiotherapeutic resistance of human malignancies. Herein, the current study set out to explore the regulatory mechanism of miR-181d...
Autores principales: | Huang, Wei, Chen, Ling, Zhu, Kean, Wang, Donglian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651739/ https://www.ncbi.nlm.nih.gov/pubmed/34876558 http://dx.doi.org/10.1038/s41420-021-00715-6 |
Ejemplares similares
-
Down-regulation of OGT promotes cisplatin resistance by inducing autophagy in ovarian cancer
por: Zhou, Fuxing, et al.
Publicado: (2018) -
MicroRNA-181a-5p functions as an oncogene in renal cell carcinoma
por: Lai, Yulin, et al.
Publicado: (2018) -
MicroRNA-181a Functions as an Oncogene in Gastric Cancer by Targeting Caprin-1
por: Lu, Qiang, et al.
Publicado: (2019) -
Inhibiting MicroRNA-503 and MicroRNA-181d with Losartan Ameliorates Diabetic Nephropathy in KKAy Mice
por: Zhu, XinWang, et al.
Publicado: (2016) -
MicroRNA-181 serves an oncogenic role in breast cancer via the inhibition of SPRY4
por: Tian, Yifu, et al.
Publicado: (2018)